Medicamentos de prescripción

Los cálculos a nivel nacional sobre las visitas a las salas de emergencias relacionadas con el consumo de drogas se obtienen de la Red de Alerta sobre el Abuso de Drogas (DAWN, por sus siglas en inglés).^1,2 La DAWN es un sistema de vigilancia de salud pública administrado por la Administración de Servicios sobre el Abuso de Sustancias y Salud Mental (SAMHSA, por sus siglas en inglés), una dependencia del Departamento de Salud y Servicios Humanos de los Estados Unidos (HHS, por sus siglas en inglés).

Stimulant medications (e.g., methylphenidate and amphetamines) are often prescribed to treat individuals diagnosed with attention-deficit hyperactivity disorder (ADHD). ADHD is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequently displayed and more severe than is typically observed in individuals at a comparable level of development. This pattern of behavior usually becomes evident in the preschool or early elementary years, and the median age of onset of ADHD symptoms is 7 years.

The principles listed below are the result of long-term research studies on the origins of drug abuse behaviors and the common elements of effective prevention programs. These principles were developed to help prevention practitioners use the results of prevention research to address drug use among children, adolescents, and young adults in communities across the country. Parents, educators, and community leaders can use these principles to help guide their thinking, planning, selection, and delivery of drug abuse prevention programs at the community level.